130 related articles for article (PubMed ID: 9523988)
1. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.
Kratz F; Beyer U; Roth T; Tarasova N; Collery P; Lechenault F; Cazabat A; Schumacher P; Unger C; Falken U
J Pharm Sci; 1998 Mar; 87(3):338-46. PubMed ID: 9523988
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization and in vitro efficacy of albumin conjugates of doxorubicin.
Kratz F; Beyer U; Collery P; Lechenault F; Cazabat A; Schumacher P; Falken U; Unger C
Biol Pharm Bull; 1998 Jan; 21(1):56-61. PubMed ID: 9477169
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
[TBL] [Abstract][Full Text] [Related]
4. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
Rodrigues PC; Beyer U; Schumacher P; Roth T; Fiebig HH; Unger C; Messori L; Orioli P; Paper DH; Mülhaupt R; Kratz F
Bioorg Med Chem; 1999 Nov; 7(11):2517-24. PubMed ID: 10632061
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo efficacy of acid-sensitive transferrin and albumin doxorubicin conjugates in a human xenograft panel and in the MDA-MB-435 mamma carcinoma model.
Kratz F; Roth T; Fichiner I; Schumacher P; Fiebig HH; Unger C
J Drug Target; 2000; 8(5):305-18. PubMed ID: 11328658
[TBL] [Abstract][Full Text] [Related]
6. Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.
Beyer U; Rothern-Rutishauser B; Unger C; Wunderli-Allenspach H; Kratz F
Pharm Res; 2001 Jan; 18(1):29-38. PubMed ID: 11336350
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
Dong DW; Tong SW; Qi XR
J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity.
Rodrigues PC; Roth T; Fiebig HH; Unger C; Mülhaupt R; Kratz F
Bioorg Med Chem; 2006 Jun; 14(12):4110-7. PubMed ID: 16546396
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells.
Berczi A; Barabas K; Sizensky JA; Faulk WP
Arch Biochem Biophys; 1993 Jan; 300(1):356-63. PubMed ID: 8424669
[TBL] [Abstract][Full Text] [Related]
10. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
11. Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy.
Kratz F; Beyer U; Roth T; Schütte MT; Unold A; Fiebig HH; Unger C
Arch Pharm (Weinheim); 1998 Feb; 331(2):47-53. PubMed ID: 9525088
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer.
Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G
Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351
[TBL] [Abstract][Full Text] [Related]
14. Novel peptide conjugates for tumor-specific chemotherapy.
Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
[TBL] [Abstract][Full Text] [Related]
15. Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor-mediated endocytosis.
Bérczi A; Ruthner M; Szüts V; Fritzer M; Schweinzer E; Goldenberg H
Eur J Biochem; 1993 Apr; 213(1):427-36. PubMed ID: 8477715
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells.
Gabor F; Wollmann K; Theyer G; Haberl I; Hamilton G
Anticancer Res; 1994; 14(5A):1943-50. PubMed ID: 7847832
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate.
Chhikara BS; Mandal D; Parang K
J Med Chem; 2012 Feb; 55(4):1500-10. PubMed ID: 22276998
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
Lemieux P; Pagé M
Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839
[TBL] [Abstract][Full Text] [Related]
19. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
20. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
Abu Ajaj K; Graeser R; Kratz F
Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]